A genome-wide senescence synthetic lethality screen identifies PARP16 as a senolytic target

Accumulation of senescent cells is increasingly viewed as a significant contributor to aging and age-related diseases. To date, the elimination of senescent cells through small molecule senolytic agents has largely relied on a limited number of repurposed agents, often leveraged from previous oncological applications. Here, we describe a CRISPR-based, genome-wide, synthetic lethal screen for senescent cells. From this screen, we identify a number of genes whose deletion appears to be well tolerated in normal proliferating cells, but whose deletion is lethal in the context of senescence. We further characterize one promising candidate gene encoding the ER-resident protein PARP16. Knockdown of PARP16 does not affect the viability of mouse or human cells but results in the death of a wide range of senescent cells. Furthermore, two distinct small molecule PARP16 inhibitors have little effect of normal cell growth but result in the selective death of senescent cells in culture and in freshly isolated human donor lung tissue explants. Together, these results demonstrate a rational strategy to identify novel senolytic therapies that could have potential applications for a wide range of age-related conditions.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-20
DOI
https://doi.org/10.1073/pnas.2627282123
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A genome-wide senescence synthetic lethality screen identifies PARP16 as a senolytic target

Shihui Liu, Toren Finkel, Haoxiang Yang, Mehdi Pirooznia et al.
2 links
Proceedings of the National Academy of Sciences
Telomeres, Telomerase, and Senescence
article

A genome-wide senescence synthetic lethality screen identifies PARP16 as a senolytic target

Shihui Liu, Toren Finkel, Haoxiang Yang, Mehdi Pirooznia, Jonathan K. Alder, Irene Alfaras, Mads Breum Larsen, Mélanie Königshoff, Shria Moturi, Delphine Beaulieu, Jie Liu, Ricardo Pineda, Yuan Liu, Shohini Ghosh-Choudhary, Bill B. Chen
article en

Abstract

Accumulation of senescent cells is increasingly viewed as a significant contributor to aging and age-related diseases. To date, the elimination of senescent cells through small molecule senolytic agents has largely relied on a limited number of repurposed agents, often leveraged from previous oncological applications. Here, we describe a CRISPR-based, genome-wide, synthetic lethal screen for senescent cells. From this screen, we identify a number of genes whose deletion appears to be well tolerated in normal proliferating cells, but whose deletion is lethal in the context of senescence. We further characterize one promising candidate gene encoding the ER-resident protein PARP16. Knockdown of PARP16 does not affect the viability of mouse or human cells but results in the death of a wide range of senescent cells. Furthermore, two distinct small molecule PARP16 inhibitors have little effect of normal cell growth but result in the selective death of senescent cells in culture and in freshly isolated human donor lung tissue explants. Together, these results demonstrate a rational strategy to identify novel senolytic therapies that could have potential applications for a wide range of age-related conditions.

Proceedings of the National Academy of SciencesVol. 123(47)
National Institutes of Health (US), University of Pittsburgh (US), National Heart, Lung, and Blood Institute (US), National Heart, Lung, and Blood Institute Division of Intramural Research (US)
Hevolution Foundation, American Heart Association, Greater Houston Community Foundation, National Institutes of Health, National Institute on Aging
Good health and well-being
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon